CY1124712T1 - Καινοτομα σχηματα προετοιμασιας-ενισχυσης που περιλαμβανουν ανοσογονα πολυπεπτιδια που κωδικοποιουνται απο πολυνουκλεοτιδια - Google Patents
Καινοτομα σχηματα προετοιμασιας-ενισχυσης που περιλαμβανουν ανοσογονα πολυπεπτιδια που κωδικοποιουνται απο πολυνουκλεοτιδιαInfo
- Publication number
- CY1124712T1 CY1124712T1 CY20211100977T CY211100977T CY1124712T1 CY 1124712 T1 CY1124712 T1 CY 1124712T1 CY 20211100977 T CY20211100977 T CY 20211100977T CY 211100977 T CY211100977 T CY 211100977T CY 1124712 T1 CY1124712 T1 CY 1124712T1
- Authority
- CY
- Cyprus
- Prior art keywords
- immunogenic polypeptides
- schemes involving
- involving polynucleotide
- encoded immunogenic
- novel priming
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με σχήματα χορήγησης που είναι ιδιαιτέρως κατάλληλα για σύνθεση εμβολίου που περιλαμβάνει πολυνουκλεοτίδια που κωδικοποιούν ανοσογόνα πολυπεπτίδια. Τα εν λόγω σχήματα χορήγησης περιλαμβάνουν την επαναλαμβανόμενη χορήγηση μίας σύνθεσης εμβολίου και ενισχύουν την ανοσοαπόκριση ενάντια στο ανοσογόνο πολυπεπτίδιο.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2012/063196 WO2014005643A1 (en) | 2012-07-05 | 2012-07-05 | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
PCT/EP2013/064286 WO2014006191A1 (en) | 2012-07-05 | 2013-07-05 | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
EP13734111.1A EP2869841B1 (en) | 2012-07-05 | 2013-07-05 | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1124712T1 true CY1124712T1 (el) | 2022-07-22 |
Family
ID=52780606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20211100977T CY1124712T1 (el) | 2012-07-05 | 2021-11-10 | Καινοτομα σχηματα προετοιμασιας-ενισχυσης που περιλαμβανουν ανοσογονα πολυπεπτιδια που κωδικοποιουνται απο πολυνουκλεοτιδια |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP2869841B1 (el) |
CY (1) | CY1124712T1 (el) |
HR (1) | HRP20211756T1 (el) |
PL (1) | PL2869841T3 (el) |
SI (1) | SI2869841T1 (el) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6180398B1 (en) | 1996-07-12 | 2001-01-30 | Virogeneitics Corporation | Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation |
PL1711518T3 (pl) | 2004-01-23 | 2010-06-30 | St Di Richerche Di Biologia Molecolare P Angeletti S P A | Nośniki szczepionek pochodzące od szympansich adenowirusów |
US8206978B2 (en) * | 2007-01-05 | 2012-06-26 | Inseron, Inc. | Green fluorescent protein optimized for expression with self-cleaving polypeptides |
WO2009025770A2 (en) * | 2007-08-17 | 2009-02-26 | Wyeth | A heterologous prime-boost immunization regimen |
GB0823497D0 (en) * | 2008-12-24 | 2009-01-28 | Isis Innovation | Immunogenic composition and use thereof |
BRPI1008018A2 (pt) | 2009-02-02 | 2016-03-15 | Okairos Ag | ácidos nucleicos de adenovírus símio e sequências de aminoácidos, vetores contendo os mesmos e uso dos mesmos |
WO2012021730A2 (en) * | 2010-08-11 | 2012-02-16 | Genvec, Inc. | Respiratory syncytial virus (rsv) vaccine |
WO2012085936A2 (en) * | 2010-12-20 | 2012-06-28 | Panacea Biotech Ltd | Recombinant respiratory syncytial virus plasmids and vaccines |
WO2012089231A1 (en) | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
CA2867955C (en) | 2012-03-22 | 2023-02-07 | Crucell Holland B.V. | Vaccine against rsv |
-
2013
- 2013-07-05 EP EP13734111.1A patent/EP2869841B1/en active Active
- 2013-07-05 PL PL13734111T patent/PL2869841T3/pl unknown
- 2013-07-05 HR HRP20211756TT patent/HRP20211756T1/hr unknown
- 2013-07-05 EP EP20213823.6A patent/EP3842068A1/en active Pending
- 2013-07-05 SI SI201331936T patent/SI2869841T1/sl unknown
-
2021
- 2021-11-10 CY CY20211100977T patent/CY1124712T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2869841A1 (en) | 2015-05-13 |
PL2869841T3 (pl) | 2022-01-24 |
EP3842068A1 (en) | 2021-06-30 |
EP2869841B1 (en) | 2021-08-25 |
SI2869841T1 (sl) | 2022-02-28 |
HRP20211756T1 (hr) | 2022-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014KN03063A (el) | ||
CY1120319T1 (el) | Πρωτεϊνες συντηξης και εμβολια συνδυασμου που περιλαμβανουν haemophilus influenzae πρωτεϊνη ε και πιλινη α | |
CY1121891T1 (el) | Τροποποιημενα με γενετικη μηχανικη πολυπεπτιδια της λυασης φαινυλαλανινης-αμμωνιας | |
CY1124979T1 (el) | Κατασκευασματα πρωτεϊνης uspa2 και χρησεις αυτων | |
CY1123563T1 (el) | Ανοσογονικα wt-1 πεπτιδια και μεθοδοι χρησης αυτων | |
CY1120730T1 (el) | Απο του στοματος χορηγουμενη δοσολογια ενωσεων glp-1 | |
CY1118735T1 (el) | Παραγωγα βενζιμιδαζολο-προλινης | |
BR112016008806A2 (pt) | Vetores para expressão de antígenos associados à próstata | |
PH12014502438A1 (en) | Prostate-associated antigens and vaccine-based immunotherapy regimens | |
MX2012009581A (es) | Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza. | |
BR112016012862A2 (pt) | formulações para vacinas para neoplasia | |
BR112014028476A2 (pt) | fragmento imunogênico de um polipeptídeo, polinucleotídeo isolado, composição farmacêutica imunogênica, métodos para tratar uma infecção, para gerar uma resposta imune em um sujeito, e para imunizar um sujeito | |
EA201790239A1 (ru) | Молекула-носитель для антигенов | |
BR112016015422A2 (pt) | formulações de vacina de frasco único | |
NZ729519A (en) | Methods and compositions for intra-nasal immunization with recombinant mva encoding flagellin | |
CY1119619T1 (el) | Παραγωγα πυριδιν-4-υλιου | |
CY1119957T1 (el) | Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος | |
CY1121491T1 (el) | Συνθεση περιλαμβανουσα συνδυασμο εκχυλισματος κουφοξυλιας και ενος στελεχους lactobacillus rhamnosus | |
BR112013030395A2 (pt) | polipeptídeo, polinucleotídeo, vetor, composição imunogênica, vacina, e, uso de uma composição imunogênica | |
CY1124738T1 (el) | Συνθεσεiς εμβολιων που περιλαμβανουν τρυπτοφανη 2,3-διοξυγεναση ή θραυσματα αυτης | |
BR112017013574A2 (pt) | conjugados de aminoácido e peptídeo e usos dos mesmos | |
EP2762153A3 (en) | Vaccine composition for mucosal administration | |
EA201590860A1 (ru) | Варианты гемагглютинина и нейраминидазы вируса свиного гриппа | |
BR112015023738B8 (pt) | Vacinas de nucleoproteina influenza | |
BR112016017242A2 (pt) | Vetores lentivirais para gerar respostas imunes contra o vírus linfotrópico-t humano do tipo 1 |